Synapmed

Synapmed is a science-led, AI-native full-service CRO delivering end-to-end solutions across the entire product lifecycle, from protocol design and pre-clinical development through clinical operations, regulatory approval, commercialization, and drug safety. With global operations spanning the USA, Europe, and Asia-Pacific, we unite physicians, pharmacists, scientists, and technologists to advance clinical research, regulatory affairs, and drug safety with precision and speed. Our science-driven, expert-led and AI-augmented platforms and services are inspection-ready, providing end-to-end support across clinical development, regulatory affairs, drug safety, medical affairs, real-world insights, and commercialization. Rooted in regulatory excellence, from 21 CFR Part 11, GCP, GVP, HIPAA, GDPR, to GAMP 5, we empower pharma to accelerate therapy delivery through smarter pathways, scalable operations, and unwavering compliance. With proven leadership across therapeutic areas, including autoimmune disorders, cardiovascular disease, neurology, respiratory medicine, oncology, pain and rare diseases and deep expertise from generics to orphan indications, we deepen capabilities, drive innovation, and ensure quality with purpose, so every project delivers meaningful real-world impact for patients.